RNAC

SEC source: 0001453687-25-000066 · wk-form4_1744406973.xml · nonDerivative · entry 5

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,636,664

F4 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $9.918 to $10.7461. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000066 · wk-form4_1744406973.xml · nonDerivative · entry 4

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 571,580

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $9.95 to $9.97. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.

SEC source: 0001453687-25-000066 · wk-form4_1744406973.xml · nonDerivative · entry 3

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 571,402

F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $8.95 to $9.91. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.

SEC source: 0001453687-25-000066 · wk-form4_1744406973.xml · nonDerivative · entry 2

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,628,698

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $9.95 to $9.97. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000066 · wk-form4_1744406973.xml · nonDerivative · entry 1

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,628,667

F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $8.95 to $9.91. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000062 · wk-form4_1742514619.xml · nonDerivative · entry 3

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,621,325

F3 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $15.00 to $15.9222. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000062 · wk-form4_1742514619.xml · nonDerivative · entry 2

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,566,436

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $14.85 to $15.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000062 · wk-form4_1742514619.xml · nonDerivative · entry 1

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,546,202

F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $13.7242 to $14.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000047 · wk-form4_1736975300.xml · nonDerivative · entry 3

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,531,462

SEC source: 0001453687-25-000047 · wk-form4_1736975300.xml · nonDerivative · entry 2

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,527,440

F2 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $17.40 to $18.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000047 · wk-form4_1736975300.xml · nonDerivative · entry 1

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,518,457

F1 · price: The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $16.40 to $17.3124. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001453687-25-000045 · wk-form4_1736802540.xml · derivative · entry 2

Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,432

Underlying: Common Stock · 9,000 shares

Expires 2033-01-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: On November 13, 2023, the Issuer acquired the private Delaware corporation which was then known as Cartesian Therapeutics, Inc. ("Old Cartesian") in accordance with the terms of an Agreement and Plan of Merger, dated November 13, 2023. Options to purchase Old Cartesian common stock held by the reporting person were converted into options to purchase shares of the Issuer's Series A Preferred Stock in connection with the merger. On April 8, 2024, these options previously exercisable for shares of Series A Preferred Stock became exercisable solely for shares of the Issuer's Common Stock.

F1 · derivative.exercise_date: The option is currently exercisable for an additional 51,089 shares of Common Stock and becomes exercisable for an additional 2,969 shares of Common Stock each month until it is fully exercisable on June 16, 2025.

SEC source: 0001453687-25-000045 · wk-form4_1736802540.xml · nonDerivative · entry 1

Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001453687-25-000037 · wk-form4_1736298303.xml · nonDerivative · entry 2

English Emily · CIK 0002019791 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,226

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000036 · wk-form4_1736298292.xml · nonDerivative · entry 2

Brunn Carsten · CIK 0001760229 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,096

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000039 · wk-form4_1736298325.xml · nonDerivative · entry 2

Miljkovic Milos · CIK 0002000282 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,393

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000040 · wk-form4_1736298335.xml · nonDerivative · entry 2

Kurtoglu Metin · CIK 0002000284 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,258

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000038 · wk-form4_1736298315.xml · nonDerivative · entry 2

Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,490

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000035 · wk-form4_1736298282.xml · nonDerivative · entry 2

Davis Blaine · CIK 0001802188 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,811

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000037 · wk-form4_1736298303.xml · nonDerivative · entry 1

English Emily · CIK 0002019791 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,132

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000036 · wk-form4_1736298292.xml · nonDerivative · entry 1

Brunn Carsten · CIK 0001760229 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,804

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000039 · wk-form4_1736298325.xml · nonDerivative · entry 1

Miljkovic Milos · CIK 0002000282 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,341

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000040 · wk-form4_1736298335.xml · nonDerivative · entry 1

Kurtoglu Metin · CIK 0002000284 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,716

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000038 · wk-form4_1736298315.xml · nonDerivative · entry 1

Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,776

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000035 · wk-form4_1736298282.xml · nonDerivative · entry 1

Davis Blaine · CIK 0001802188 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,839

F1 · price: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

SEC source: 0001453687-25-000020 · wk-form4_1736198391.xml · derivative · entry 4

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2035-01-01

SEC source: 0001453687-25-000020 · wk-form4_1736198391.xml · nonDerivative · entry 1

SPRINGER TIMOTHY A · CIK 0001055624 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,510,495

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

SEC source: 0001453687-25-000016 · wk-form4_1736198350.xml · derivative · entry 2

COX CARRIE SMITH · CIK 0001110753 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Common Stock · 8,000 shares

Expires 2035-01-01

SEC source: 0001453687-25-000016 · wk-form4_1736198350.xml · nonDerivative · entry 1

COX CARRIE SMITH · CIK 0001110753 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,629

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

F2 · balance_after: On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001453687-25-000024 · wk-form4_1736198433.xml · derivative · entry 2

ZENNER PATRICK J · CIK 0001139036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2035-01-01

SEC source: 0001453687-25-000024 · wk-form4_1736198433.xml · nonDerivative · entry 1

ZENNER PATRICK J · CIK 0001139036 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,374

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

F2 · balance_after: On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001453687-25-000026 · wk-form4_1736198457.xml · derivative · entry 2

English Emily · CIK 0002019791 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,400

Underlying: Common Stock · 47,400 shares

Expires 2035-01-01

F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000026 · wk-form4_1736198457.xml · nonDerivative · entry 1

English Emily · CIK 0002019791 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,023

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000028 · wk-form4_1736198480.xml · derivative · entry 2

Brunn Carsten · CIK 0001760229 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,100

Underlying: Common Stock · 169,100 shares

Expires 2035-01-01

F3 · derivative.exercise_date: This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000028 · wk-form4_1736198480.xml · nonDerivative · entry 1

Brunn Carsten · CIK 0001760229 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,367

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

F2 · balance_after: On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001453687-25-000015 · wk-form4_1736198338.xml · derivative · entry 2

DeSilva Nishan M · CIK 0001492386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2035-01-01

SEC source: 0001453687-25-000015 · wk-form4_1736198338.xml · nonDerivative · entry 1

DeSilva Nishan M · CIK 0001492386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,766

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

F2 · balance_after: On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001453687-25-000027 · wk-form4_1736198467.xml · derivative · entry 2

Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,400

Underlying: Common Stock · 47,400 shares

Expires 2035-01-01

F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000027 · wk-form4_1736198467.xml · nonDerivative · entry 1

Jewell Christopher M · CIK 0002000226 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,040

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000025 · wk-form4_1736198446.xml · derivative · entry 2

Davis Blaine · CIK 0001802188 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,600

Underlying: Common Stock · 64,600 shares

Expires 2035-01-01

F3 · derivative.exercise_date: This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000025 · wk-form4_1736198446.xml · nonDerivative · entry 1

Davis Blaine · CIK 0001802188 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,800

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

F2 · balance_after: On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

SEC source: 0001453687-25-000023 · wk-form4_1736198423.xml · derivative · entry 2

Miljkovic Milos · CIK 0002000282 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,000

Underlying: Common Stock · 56,000 shares

Expires 2035-01-01

F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000023 · wk-form4_1736198423.xml · nonDerivative · entry 1

Miljkovic Milos · CIK 0002000282 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,273

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.

SEC source: 0001453687-25-000022 · wk-form4_1736198413.xml · derivative · entry 3

Kalayoglu Murat · CIK 0002000002 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2035-01-01

SEC source: 0001453687-25-000022 · wk-form4_1736198413.xml · nonDerivative · entry 1

Kalayoglu Murat · CIK 0002000002 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508,977

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

SEC source: 0001453687-25-000021 · wk-form4_1736198402.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2035-01-01

SEC source: 0001453687-25-000021 · wk-form4_1736198402.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,366

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

SEC source: 0001453687-25-000019 · wk-form4_1736198381.xml · derivative · entry 2

Malik Kemal · CIK 0001797921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 7,800 shares

Expires 2035-01-01

SEC source: 0001453687-25-000019 · wk-form4_1736198381.xml · nonDerivative · entry 1

Malik Kemal · CIK 0001797921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,533

F1 · acquired: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.

SEC source: 0001453687-25-000018 · wk-form4_1736198370.xml · derivative · entry 2

Kurtoglu Metin · CIK 0002000284 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,400

Underlying: Common Stock · 47,400 shares

Expires 2035-01-01

F2 · derivative.exercise_date: This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.